Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity

C. Traversari, G. Ferrari, L. Grazioli, D. Ballinari, M. P. Colombo, C. Castelli, M. A. Pierotti, G. Parmiani

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)106-114
Number of pages9
JournalExperimental and Clinical Immunogenetics
Volume4
Issue number2
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Immunology
  • Genetics(clinical)
  • Genetics

Cite this

Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity. / Traversari, C.; Ferrari, G.; Grazioli, L.; Ballinari, D.; Colombo, M. P.; Castelli, C.; Pierotti, M. A.; Parmiani, G.

In: Experimental and Clinical Immunogenetics, Vol. 4, No. 2, 1987, p. 106-114.

Research output: Contribution to journalArticle

@article{b61833cfda7a489bbeba52deb96353a5,
title = "Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity",
author = "C. Traversari and G. Ferrari and L. Grazioli and D. Ballinari and Colombo, {M. P.} and C. Castelli and Pierotti, {M. A.} and G. Parmiani",
year = "1987",
language = "English",
volume = "4",
pages = "106--114",
journal = "Experimental and Clinical Immunogenetics",
issn = "0254-9670",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity

AU - Traversari, C.

AU - Ferrari, G.

AU - Grazioli, L.

AU - Ballinari, D.

AU - Colombo, M. P.

AU - Castelli, C.

AU - Pierotti, M. A.

AU - Parmiani, G.

PY - 1987

Y1 - 1987

UR - http://www.scopus.com/inward/record.url?scp=0023179409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023179409&partnerID=8YFLogxK

M3 - Article

C2 - 2978840

AN - SCOPUS:0023179409

VL - 4

SP - 106

EP - 114

JO - Experimental and Clinical Immunogenetics

JF - Experimental and Clinical Immunogenetics

SN - 0254-9670

IS - 2

ER -